In addition to its use in ulcerative colitis clinical trials[2-7] and its effectiveness in various models of colitis[30-35], BPC 157 reduces high myeloperoxidase (MPO) activity in colonic tissue[33], heals fistulas[36-38], rescues failed anastomosis healing[30,34,39,40] and markedly improves intestinal adaptation following massive bowel resection[40]
Tirzepatide, a dual GLP-1 and GIP receptor agonist, offers a pathway forward when prescribed with appropriate medical oversight
TaylorMKSullivanDKMahnkenJDBurnsJMSwerdlowRH.Feasibility and efficacy data from a ketogenic diet intervention in Alzheimers disease
Understanding why these side effects occur, how to manage them effectively, and when to seek professional advice helps patients make informed decisions about their diabetes treatment whilst maintaining safety and quality of life
Were scaling a drug revolution faster than we understand it